Vax-Immune DBA LabReady of Houston, TX at MEDICA 2021 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option
Manufacturers Service

Vax-Immune DBA LabReady

3718, Sunset Boulevard Suite 301, 77005 Houston, TX
USA

Submit your contact details

Provide your contact details to the exhibitor. Optionally, you may also add a personal message.

Please log in

You must be logged in to send the contact request.

An error has occurred

Please check your internet connection or try again later.

Message has been sent

Your message to the exhibitor was sent successfully.

This company is co-exhibitor of
Messe Düsseldorf North America

Hall map

MEDICA 2021 hall map (Hall 3): stand C26-3

Fairground map

MEDICA 2021 fairground map: Hall 3

Contact

Prof. Leonard Weisman M.D.

Phone
7136620077

Email
medica2021@labready.com

Please log in

You must be logged in to use matchmaking

Please log in for matchmaking

Registration is required to use the networking service and a separate registration for matchmaking. Please register for Matchmaking first.

Let's get started!

Welcome to Matchmaking. Would you like to get in touch with ?

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.04  Microbiology testing
  • 03.04.01  Bacteriology testing in microbiology

Our products

Product category: Bacteriology testing in microbiology

LabReady Group B Strep (GBS) Automated Sample Prep®

Accelerate the speed of GBS diagnosis by at least 24 hours and eliminate the cost of cold-chain.

Product Overview
LabReady (GBS) Prep® is an Enriched Specimen Collection and Transport System redefines the 85-year-old specimen collection process–leading to faster, more reliable diagnoses. LabReady has automated and has compressed the required 18-24 hours sample enrichment process for bacteria down to a 2.5-ounce device. Our CE marked Automated Sample Prep System® enriches specimens with zero hands-on time before it reaches the lab. Because LabReady samples are already enriched, samples can be tested using any assay upon arrival or batched without need for refrigeration for line testing later in the day.

By eliminating the need for manual enrichment, your laboratory can redeploy resources to more value-added activities and batch test samples– thereby improving workflow. Samples collected with LabReady don’t need to be shipped under cold-chain and remained viable at 109 CFUs for 14 days without refrigeration. You also benefit from eliminating the errors that can result from pre-analytical work while increasing margins.

LabReady Benefits
  • Accelerates diagnosis speed by 24 hours
  • Eliminates required costs for enrichment and cold-chain
  • Keeps samples viable at 109 CFUs for 14 days without refrigeration
  • Enables batch-testing of bacterial samples without new equipment
  • Prevents sample integrity loss due to transport delays, temperature, etc
Looking to maximize productivity and minimize diagnosis time for your customers? Pair LabReady GBS Prep® with LabReady’s Enriched Rapid Test System® for GBS to allow lower skilled technicians to simply screen infection samples in one-step without having to mix reagents.

More Less

Product category: Bacteriology testing in microbiology

LabReady Group A Strep (Strep A) Automated Sample Prep®

Accelerate the speed of group A Streptococcus (Strep A) diagnosis by at least 24 hours and eliminate the cost of cold-chain.

Product Overview
LabReady Strep A Prep® is an Enriched Specimen Collection and Transport System redefines the 85-year-old specimen collection process–leading to faster, more reliable diagnoses. LabReady has automated and has compressed the required 18-24 hours sample enrichment process for bacteria down to a 2.5-ounce device. Our CE marked Automated Sample Prep System® enriches specimens with zero hands-on time before it reaches the lab. Because LabReady samples are already enriched, samples can be tested using any assay upon arrival or batched without need for refrigeration for line testing later in the day.

By eliminating the need for manual enrichment, your laboratory can redeploy resources to more value-added activities and batch test samples– thereby improving workflow. Samples collected with LabReady don’t need to be shipped under cold-chain and remained viable at 109 CFUs for 14 days without refrigeration. You also benefit from eliminating the errors that can result from pre-analytical work while increasing margins.

Looking to maximize productivity and minimize diagnosis time for your customers? Pair LabReady Strep A Prep® with LabReady’s Enriched Rapid Test System® for Strep A to allow lower skilled technicians to simply screen infection samples in one-step without having to mix reagents.

More Less

Company news

Date

Topic

16 Feb 2021

Release: LabReady Received CE Marking Enabling Faster, More Accurate Infection Diagnosis in the EU

Vax-Immune Diagnostics announces today it has received CE Mark approval for its first-in-class, medical device, LabReady® GBS. LabReady’s Group B Strep product is the first in Vax-Immune Diagnostics line up of women’s health solutions that helps avoid life-threatening complications and expensive consequences for mothers and their babies.

With CE Mark approval, LabReady is now available to European physicians, patients, and hospital systems.

The brainchild of Dr. Leonard E. Weisman, renowned neonatologist, LabReady aims to protect patients from the dangers and costs of misdiagnosis by giving physicians and microbiology labs a safer, smarter, and more economical way to treat patients’ sample.

“I have spent over 40 years watching newborns die or have developmental problems due to infections in the pregnant moms which could have been avoided. By using LabReady, infections can be detected prior to delivery, treated appropriately, thereby reducing infant mortality related to infection,” states Dr. Weisman.

Vax-Immune Diagnostics estimates the LabReady solution will be available in European markets as soon as Summer, 2021. LabReady will be available through provider channels, as well as in direct to consumer/home testing markets. Vax-Immune Diagnostics hopes to greatly decrease global infection mortality by making high-quality specimen collection accessible to everyone around the world.


About Vax-Immune Diagnostics and LabReady:

Vax-Immune Diagnostics, founded by Dr. Leonard E. Weisman, is a healthcare technology company that has built the world’s first and only full-integrated specimen enrichment transport system, LabReady, to help the medical community quickly and more accurately detect infectious diseases.

More Less

About us

Company portrait

LabReady® is redefining the 85-year-old specimen collection process–leading to faster, more reliable diagnoses. LabReady has automated and has compressed the required sample enrichment process for bacterial infections down to a 2.5-ounce device. Our CE marked Automated Sample Prep System® enriches bacterial specimens with zero hands-on time before it reaches the lab.

Company data

Number of employees 1-19
Area of business
  • Imaging and diagnostics / medical equipment and devices
  • Diagnostic tests